You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 14, April 14, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited

E. Barrett-Connor, D. L. Wingard and M. H. Criqui
Department of Community and Family Medicine, School of Medicine, University of California, San Diego, La Jolla 92093.

Postmenopausal estrogen use and risk factors for heart disease were assessed in 1057 women, aged 50 to 79 years, who were enrolled in an ongoing study of residents of an upper-middle-class community. From 1984 through 1987, thirty-one percent of the women reported current estrogen use, a rate equivalent to that determined in one survey of the same population done from 1972 through 1974. Compared with nonusers, current users did not have a more favorable cardiac risk factor profile before use, but users were more likely to have had a surgically induced menopause and to have been estrogen users during the survey done from 1972 through 1974. Similar to our earlier findings, current estrogen use was associated with lower weight, diastolic blood pressure, and fasting plasma glucose level than nonuse. Levels of low-density lipoprotein cholesterol were inversely related to estrogen dose; levels of high-density lipoprotein cholesterol were positively related to the duration of use. In this cross-sectional study, blood pressure and lipoprotein and plasma glucose levels were similar in women receiving estrogen alone and in women receiving combination estrogen and progestin therapy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Commentary: Hormone replacement therapy and coronary heart disease: four lessons
Petitti
Int J Epidemiol 2004;33:461-463.
FULL TEXT  

Oestrogen plus progestogen did not reduce the risk of coronary heart disease in postmenopausal women
Crandall
Evid. Based Med. 2004;9:52-52.
FULL TEXT  

Perspectives on the Women's Health Initiative Trial of Hormone Replacement Therapy
Grimes and Lobo
Obstet Gynecol 2002;100:1344-1353.
ABSTRACT | FULL TEXT  

Hormone Replacement Effects on Endothelial Function Measured in the Forearm Resistance Artery in Normocholesterolemic and Hypercholesterolemic Postmenopausal Women
Sanada et al.
J. Clin. Endocrinol. Metab. 2002;87:4634-4641.
ABSTRACT | FULL TEXT  

Low-Dose Estrogen Supplementation Improves Vascular Function in Hypogonadal Men
Komesaroff et al.
Hypertension 2001;38:1011-1016.
ABSTRACT | FULL TEXT  

Usual Dietary Isoflavone Intake Is Associated with Cardiovascular Disease Risk Factors in Postmenopausal Women
Goodman-Gruen and Kritz-Silverstein
J. Nutr. 2001;131:1202-1206.
ABSTRACT | FULL TEXT  

Effect of Estrogen Replacement Therapy on Endothelial Function in Peripheral Resistance Arteries in Normotensive and Hypertensive Postmenopausal Women
Higashi et al.
Hypertension 2001;37:651-657.
ABSTRACT | FULL TEXT  

Sex differences in outcome following community-based cardiopulmonary arrest
Pell et al.
Eur Heart J 2000;21:239-244.
ABSTRACT  

Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function
Teede et al.
J Am Coll Cardiol 1999;34:131-137.
ABSTRACT | FULL TEXT  

Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Keating et al.
ANN INTERN MED 1999;130:545-553.
ABSTRACT | FULL TEXT  

Hormones and Vasoprotection
Oparil
Hypertension 1999;33:170-176.
ABSTRACT | FULL TEXT  

Estrogen Supplementation Decreases Norepinephrine-Induced Vasoconstriction and Total Body Norepinephrine Spillover in Perimenopausal Women
Sudhir et al.
Hypertension 1997;30:1538-1543.
ABSTRACT | FULL TEXT  

Estrogen Replacement
Sullivan
Circulation 1996;94:2699-2702.
FULL TEXT  

Estrogens for Prevention of Coronary Heart Disease: Putting the Brakes on the Bandwagon
Rossouw
Circulation 1996;94:2982-2985.
FULL TEXT  

The Association of Hyperestrogenemia With Coronary Thrombosis in Men
Phillips et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:1383-1387.
ABSTRACT | FULL TEXT  

Estrogen Enhances Basal Nitric Oxide Release in the Forearm Vasculature in Perimenopausal Women
Sudhir et al.
Hypertension 1996;28:330-334.
ABSTRACT | FULL TEXT  

Identification of Authentic Estrogen Receptor in Cultured Endothelial Cells: A Potential Mechanism for Steroid Hormone Regulation of Endothelial Function
Venkov et al.
Circulation 1996;94:727-733.
ABSTRACT | FULL TEXT  

Utilisation of hormone replacement therapy by women doctors
Isaacs et al.
BMJ 1995;311:1399-1401.
ABSTRACT | FULL TEXT  

Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
Nabulsi et al.
NEJM 1993;328:1069-1075.
ABSTRACT | FULL TEXT  

Postmenopausal Hormone-Replacement Therapy
Martin and Freeman
NEJM 1993;328:1115-1117.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.